The Pharmacological Rationale for Methadone Treatment of Narcotic Addiction

Date:
January 1995
Author:
R.G. Newman

Despite over a quarter century of remarkably consistent reports from throughout the world of favorable results with the use of methadone to treat heroin addiction, this modality remains exceedingly controversial. Even among those who utilize methadone in caring for addicts, there is intense debate over optimal dosages, duration of treatment and other aspects of the medical care which is rendered. Ironically, the polarization seems to reflect a misunderstanding of the basis pharmacological rationale for methadone treatment.

In this paper the pharmacological principles which apply to narcotics in general, and to methadone in particular, are presented. The author notes that the effects (and, in maintained patients, the lack of effect with respect to euphoria) of methadone are absolutely free from any controversy. Physicians and policy makers must be guided by these straightforward, unequivocal pharmacological properties in determining how methadone should be utilized in the management of patients with a chronic, potentially deadly illness.

The publication is available below in English, Chinese, Farsi, French, and Russian.

Relevant drug policy publications are almost nonexistent in languages other than English. With the help of leading experts, the Open Society Foundations Global Drug Policy Program is publishing key documents in translation.

back to the top of the page
Related Information

Drug Policy in Portugal: The Benefits of Decriminalizing Drug Use
August 2011
This Open Society Foundations report documents how decriminalization can reduce drug consumption, dependence, recidivism, and HIV infection, and create safer communities for all.

From the Mountaintops
October 2010
This Open Society Foundations report examines drug policy change in Switzerland and its lessons for the rest of the world.

Time to Act: A Call for Comprehensive Responses to HIV in People Who Use Drugs
July 2010
This paper reviews identifies synergies between biomedical science, public health, and human rights to advocate for cost-effective and evidence-based interventions, including needle exchange, opioid substitution therapy, and expanded access to HIV treatment.

International Drug Policy Consortium: Five Policy Principles
January 2009
This publication documents the five principles for advocacy work that members of the International Drug Policy Consortium, an Open Society Institute grantee, have agreed to promote. Available in English, Chinese, Farsi, French, and Russian.

The United Nations Review of Global Policy on Illegal Drugs: An Advocacy Guide for Civil Society
June 2008
A guide for NGOs on how the UN review process of global drug policy is unfolding, and ideas on how organizations can engage in effective advocacy.

About  |  Initiatives  |  Grants, Scholarships & Fellowships  |  Resource Center  |  Newsroom  |  Site Map  |  Legal  |  Contact


Creative Commons License
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-Noncommercial-No Derivative License.
©2012 Open Society Foundations. Some rights reserved.